Sevelamer versus calcium-based phosphate binders in chronic kidney disease: what should we conclude from the evidence to date?
Johnson
David W
DW
D002614:Chelating Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*; D010710:Phosphates / Q000378:metabolism; D011073:Polyamines / Q000627:therapeutic use*; D000069603:Sevelamer
D002614:Chelating Agents; D010710:Phosphates; D011073:Polyamines; D000069603:Sevelamer